Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × tafasitamab × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 31 fludarabine 23 fludarabine phosphate 22 Tacrolimus 22 Whole-Body Irradiation 21 Mycophenolic Acid 19 Busulfan 14 Melphalan 11 thymoglobulin 10 Methotrexate 10 Granulocyte Colony-Stimulating Factor 10 Antilymphocyte Serum 10 Stem Cell Transplantation 9 Rituximab 9 Filgrastim 8 Thiotepa 7 Cyclosporine 7 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Cytarabine 6 Nivolumab 5 Bortezomib 5 Alemtuzumab 5 trametinib 4 Sirolimus 4 Hematopoietic Stem Cell Transplantation 4 Dexamethasone 4 Cyclosporins 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡